Markets•2 reports
25DOOM SCORE
Novartis trial setback sends shares lower
Switzerland
First seen: Sep 8, 2026, 8:48 AM UTCUpdated: Sep 8, 2026, 11:47 AM UTC
WHAT HAPPENED
Novartis shares fell after a setback in the company's latest clinical trial. The supplied information does not specify the drug, trial outcome or scale of the decline.
SO WHAT?
A major pharmaceutical trial failure can affect investors and the development prospects of a potential treatment.
FOR ME
Impact on Switzerland
Checking cached analysis...
MARKETS
Market impact
Checking cached analysis...
COVERAGE